Exemestan Viatris
Exemestan Viatris is a medicine authorised by Swissmedic under authorisation number 61523. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 May 2012 and the authorisation is valid without a time limit. ATC code L02BG06 places the medicine in the group Endocrine therapy.
| Authorisation number | 61523 |
|---|---|
| Name | Exemestan Viatris |
| Full name | Exemestan Viatris, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BG06 |
| First authorisation | 04 May 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Exemestan Viatris, Filmtabletten | B | 04 May 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 30 | Tablette(n) | L02BG06 | 07.16.2. | B |
| 7 | 100 | Tablette(n) | L02BG06 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Exemestan Viatris authorised in Switzerland?
Yes. Exemestan Viatris is authorised by Swissmedic under authorisation number 61523, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Exemestan Viatris have?
Exemestan Viatris is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Exemestan Viatris?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.